[1]梁盛兴,邹俐爱,邱 恒,等.1990—2021年中国归因于高BMI的慢性肾病疾病负担研究[J].卫生经济研究,2025,42(04):42-46,52.
　LIANG Shengxing,ZOU Liai,QIU Heng,et al.Study on the Disease Burden of Chronic Kidney Disease Attributed to High BMI in China from 1990 to 2021[J].Journal Press of Health Economics Research,2025,42(04):42-46,52.
点击复制

1990—2021年中国归因于高BMI的慢性肾病疾病负担研究
分享到：

卫生经济研究[ISSN:1004-7778/CN:33-1056/F]

卷:
42
期数:
2025年04期
页码:
42-46,52
栏目:
成本与费用
出版日期:
2025-04-02

文章信息/Info

Title:
Study on the Disease Burden of Chronic Kidney Disease Attributed to High BMI in China from 1990 to 2021
作者:
梁盛兴1; 2; 邹俐爱2; 3; 邱 恒2; 邓光璞2; 张远妮2; 姚奕婷2; 3; 王文昱2; 3; 李则杨4; 李文源1; 2
1.南方医科大学公共卫生学院，广东 广州 510515
2.南方医科大学南方医院，广东 广州 510515
3.南方医科大学卫生与健康管理研究院，广东 广州 510515
4.南方医科大学卫生管理学院，广东 广州 510515
Author(s):
LIANG Shengxing;  ZOU Liai;  QIU Heng;  DENG Guangpu;  ZHANG Yuanni;  YAO Yiting;  WANG Wenyu;  LI Zeyang;  LI Wenyuan
School of Public Health, Southern Medical University, Guangzhou Guangdong 510515, China
关键词:
身体质量指数; 慢性肾病; 疾病负担
Keywords:
body mass index;  chronic kidney disease;  disease burden
分类号:
R692;R181.3
文献标志码:
A
摘要:
目的：分析中国归因于高身体质量指数（BMI）的慢性肾病疾病负担，为制定慢性肾病防治策略提供理论依据。方法：从全球疾病负担数据库中获取1990—2021年中国归因于高BMI的慢性肾病死亡数、死亡率、DALY、DALY率，进行统计学描述及长期变化趋势分析。结果：1990—2021年中国归因于高BMI的慢性肾病死亡率、标化死亡率、DALY率及标化DALY率均成上升趋势，26.46%的慢性肾病死亡归因于高BMI；2021年的标化死亡率与标化DALY率分别为2.83/10万、66.97/10万，与1990年相比分别增长了57.22%、53.99%，年均变化百分比（AAPC）分别为1.37（95%CI:1.31~1.43）、1.37（95%CI:1.31~1.41）。结论：中国归因于高BMI的慢性肾病疾病负担不断加重，应重点关注男性和老年人群，采取相应措施减轻高BMI带来的慢性肾病疾病负担。
Abstract:
Objective To analyze the disease burden of chronic kidney disease(CKD) attributed to high body mass index (BMI) in China from 1990 to 2021, and to provide scientific evidences for the development of CKD prevention and treatment strategies. Methods Data on deaths, mortality rates, disability-adjusted life years(DALY), and standardized DALY rates attributed to high BMI in China from 1990 to 2021 were obtained from the Global Burden of Disease Database. Descriptive analysis and long-term trend analysis were conducted. Results From 1990 to 2021, mortality rates, standardized mortality rates, DALY rates, and standardized DALY rates for CKD attributed to high BMI in China showed an upward trend, with 26.46% of CKD deaths attributed to high BMI. In 2021, standardized mortality rate and standardized DALY rate in China were 2.83 and 66.97 per 100,000 respectively, representing an increase of 57.22% and 53.99% respectively compared to 1990, and the average annual percent change(AAPC) were 1.37(95%CI:1.31~1.43) and 1.37(95%CI:1.31~1.41) respectively. Conclusion The disease burden of CKD attributed to high BMI in China is increasing. Attention should be focused on men and the elderly, and corresponding measures should be taken to effectively reduce the disease burden of CKD attributed to high BMI.

参考文献/References:

[1] Jadoul M,Aoun M,Masimango I M.The major global burden of chronic kidney disease[J].Lancet Glob Health,2024,12(03):e342-e343.
[2] KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease[J].Kidney Int,2024,105(4S):S117-S314.
[3] Chesnaye N C,Ortiz A,Zoccali C,et al.The impact of population ageing on the burden of chronic kidney disease[J].Nat Rev Nephrol, 2024,20(09):569-585.
[4] Chen Y,Dabbas W,Gangemi A,et al.Obesity Management and Chronic Kidney Disease[J].Semin Nephrol,2021,41(04):392-402.
[5] Chen K,Shen Z,Gu W,et al.Prevalence of obesity and associated complications in China:a cross-sectional,real-world study in 15.8 million adults[J].Diabetes Obes Metab,2023,25(11):3390-3399.
[6] Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations,1990-2021:a systematic analysis for the Global Burden of Disease Study 2021[J].Lancet, 2024,403(10440):2162-2203.
[7] Cole T J,Lobstein T.Extended international(IOTF) body mass index cut-offs for thinness, overweight and obesity[J].Pediatr Obes, 2012,7(04):284-294.
[8] Lee M,Lakshminarayan K,Sedaghat S,et al.Population attributable fraction of total stroke associated with modifiable risk factors in the United States[J].Am J Epidemiol,2024,193(12):1712-1719.
[9] 李立明，饶克勤，孔灵芝，等.中国居民2002年营养与健康状况调查[J].中华流行病学杂志，2005（07）：478-484.
[10] 马靖茹，王智奕，孙美晨，等.国超重肥胖流行状况与防控工作进展[J].中国预防医学杂志，2024，25（04）：406-412.
[11] 中国居民营养与慢性病状况报告（2020年）[J].营养学报，2020，42（06）：521.
[12] 李瑶玥，王桂新.社会经济因素对中国居民肥胖的影响[J].人口与发展，2022，28（05）：107-125.
[13] 吴菲.社会决定抑或身材筛选？社会经济地位与肥胖的性别化因果关系[J].社会，2021，41（02）：218-242.
[14] 柯昌荣，赵树勇，玄美燕，等.中国1990—2019年慢性肾病疾病负担及变化趋势分析[J].中国预防医学杂志，2021，22（10）：757-761.
[15] 柯倩，宇传华，刘晓雪，等.基于GBD数据的中国慢性肾病疾病 负担现状及趋势分析[J].公共卫生与预防医学，2021，32（05）：1-5.
[16] 张凯，杨丽，彭瑞，等.1990—2019年中国归因于高盐饮食的慢性肾病疾病负担研究及趋势预测[J].现代预防医学，2023，50（15）：2737-2743.
[17] Denic A,Rule A D,Glassock R J.Healthy and unhealthy aging on kidney structure and function:hum an studies[J].Curr Opin Nephrol Hypertens,2022,31(03):228-234.
[18] Denic A,Lieske J C,Chakkera H A,et al.The substantial loss of nephrons in healthy human kidneys with aging[J].J Am Soc Nephrol,2017,28(01):313-320.
[19] 陆杰华，林嘉琪.重度老龄化社会的人口特征、风险识别与战略应对[J].中国特色社会主义研究，2023（01）：59-68.
[20] Wang H,Zhai F.Programme and policy options for preventing obesity in China[J].Obes Rev,2013,14(02):134-140.
[21] Xue Y,Ruan Z,Ung C,et al.Policy analysis of system responses to addressing and reversing the obesity trend in China:a documentary research[J].BMC Public Health,2023,23(01):1198.
[22] 穆光宗，张团.我国人口老龄化的发展趋势及其战略应对[J]. 华中师范大学学报（人文社会科学版），2011，50（05）：29-36.
[23] 姜勇.我国成人超重肥胖流行现状、变化趋势及健康危害研 究[D].北京：中国疾病预防控制中心，2013.
[24] 倪国华，张璟，郑风田.中国肥胖流行的现状与趋势[J].中国食物与营养，2013，19（10）：70-74.
[25] Wang Y,Zhao L,Gao L,et al.Health policy and public health implications of obesity in China[J].Lancet Diabetes Endocrinol,2021,9(07):446-461.
[26] 詹思怡，许锐恒，傅传喜.重视第四级预防构建五级预防理论框架[J].中国公共卫生，2020，36（12）：1729-1733.
[27] 马冠生.我国预防控制肥胖策略的探讨[J].中国食物与营养，2012，18（05）：5-8.
[28] Perdomo C M,Cohen R V,Sumithran P,et al.Contemporary medical, device,and surgical therapies for obesity in adults[J].Lancet, 2023,401(10382):1116-1130.
[29] Petridou A,Siopi A,Mougios V.Exercise in the management of obesity[J].Metabolism,2019,92:163-169.
[30] Smethers A D,Rolls B J.Dietary management of obesity:cornerstones of healthy eating patterns[J].Med Clin North Am,2018,102(01):107-124.
[31] Kalantar-Zadeh K,Li P K. Strategies to prevent kidney disease and its progression[J].Nat Rev Nephrol,2020,16(03):129-130.

更新日期/Last Update: 2025-04-02